Avalo Therapeutics Inc (AVTX) Insider Trading
- $1,958,101.39
- $1,675,144.18
- June 26, 2023
- Caissa Capital Management Ltd.
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
June 26, 2023 | Major Shareholder | 2,746,138 | $0.61 | Sell | $1,675,144.18 | |
June 20, 2023 | Major Shareholder | 2,000 | $4.14 | Buy | $8,280.00 | |
June 16, 2023 | Major Shareholder | 3,000 | $3.90 | Buy | $11,700.00 | |
June 14, 2023 | Major Shareholder | 6,000 | $3.48 | Buy | $20,880.00 | |
June 12, 2023 | Major Shareholder | 2,149 | $4.34 | Buy | $9,326.66 | |
June 9, 2023 | CFO | 511 | $3.42 | Buy | $1,747.62 | |
June 9, 2023 | CEO | 4,000 | $3.42 | Buy | $13,680.00 | |
May 30, 2023 | Major Shareholder | 671 | $2.87 | Buy | $1,925.77 | |
May 25, 2023 | Major Shareholder | 2,000 | $2.77 | Buy | $5,540.00 | |
May 22, 2023 | Major Shareholder | 7,000 | $3.34 | Buy | $23,380.00 | |
May 18, 2023 | Major Shareholder | 13,121 | $3.29 | Buy | $43,168.09 | |
May 15, 2023 | Major Shareholder | 1,715 | $2.55 | Buy | $4,373.25 | |
May 12, 2023 | Major Shareholder | 2,285 | $2.45 | Buy | $5,598.25 | |
May 8, 2023 | Major Shareholder | 5,000 | $2.62 | Buy | $13,100.00 | |
May 4, 2023 | Major Shareholder | 15,000 | $2.79 | Buy | $41,850.00 | |
April 26, 2023 | Major Shareholder | 425 | $2.97 | Buy | $1,262.25 | |
April 24, 2023 | Major Shareholder | 12,500 | $3.06 | Buy | $38,250.00 | |
April 20, 2023 | Major Shareholder | 5,000 | $3.08 | Buy | $15,400.00 | |
April 17, 2023 | Major Shareholder | 15,000 | $2.96 | Buy | $44,400.00 | |
April 10, 2023 | Major Shareholder | 31,329 | $2.28 | Buy | $71,430.12 | |
Dec. 9, 2022 | CEO | 2,083 | $4.42 | Buy | $9,206.86 | |
March 14, 2022 | Director | 100,000 | $0.65 | Buy | $65,000.00 | |
March 10, 2022 | Director | 26,000 | $0.70 | Buy | $18,200.00 | |
March 7, 2022 | Director | 325,000 | $0.66 | Buy | $214,500.00 | |
March 3, 2022 | Director | 50,000 | $0.71 | Buy | $35,500.00 | |
Feb. 24, 2022 | Director | 100,000 | $0.80 | Buy | $80,000.00 | |
Feb. 22, 2022 | Director | 83,000 | $0.77 | Buy | $63,910.00 | |
Feb. 17, 2022 | Director | 150,000 | $0.81 | Buy | $121,500.00 | |
Jan. 20, 2022 | Director | 12,000 | $0.85 | Buy | $10,200.00 | |
Jan. 18, 2022 | Director | 206,300 | $0.88 | Buy | $181,544.00 | |
Jan. 14, 2022 | Director | 85,000 | $0.93 | Buy | $79,050.00 | |
Jan. 12, 2022 | Director | 57,300 | $1.04 | Buy | $59,592.00 | |
Jan. 10, 2022 | Director | 491,097 | $0.99 | Buy | $486,186.03 | |
Jan. 7, 2022 | Director | 137,900 | $1.04 | Buy | $143,416.00 | |
Dec. 10, 2021 | CFO | 2,231 | $1.57 | Buy | $3,502.67 | |
Dec. 10, 2021 | CAO | 955 | $1.57 | Buy | $1,499.35 | |
Dec. 10, 2021 | Insider | 6,371 | $1.57 | Buy | $10,002.47 |
Insiders are both buying and selling Avalo Therapeutics Inc stock.
The insider traders at Avalo Therapeutics Inc are: Caissa Capital Management Ltd., Armistice Capital, Llc, Christopher Ryan Sullivan, Garry Arthur Neil, H Jeffrey Wilkins, and Schond L Greenway
The most active insider trader at Avalo Therapeutics Inc is Caissa Capital Management Ltd. with 17 trades.
Armistice Capital, Llc has sold the most Avalo Therapeutics Inc stock with a total value of $3,350,288.36.
Armistice Capital, Llc has bought the most Avalo Therapeutics Inc stock with a total value of $1,623,598.03.
The most recent insider trade for Avalo Therapeutics Inc was on June 26, 2023.
The single biggest insider buy for Avalo Therapeutics Inc was from Armistice Capital, Llc with a total value of $486,186.03 on Jan. 10, 2022.
The single biggest insider sell for Avalo Therapeutics Inc was from Armistice Capital, Llc with a total value of $1,675,144.18 on June 26, 2023.